Clearstead Advisors’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7K Buy
34
+32
+1,600% +$11.3K ﹤0.01% 1897
2026
Q1
$643 Sell
2
-24
-92% -$7.15K ﹤0.01% 2096
2025
Q4
$6.72K Sell
26
-1,192
-98% -$271K ﹤0.01% 1966
2025
Q3
$276K Buy
1,218
+6
+0.5% +$1.23K ﹤0.01% 804
2025
Q2
$253K Hold
1,212
﹤0.01% 822
2025
Q1
$236K Hold
1,212
﹤0.01% 779
2024
Q4
$274K Hold
1,212
﹤0.01% 758
2024
Q3
$252K Hold
1,212
﹤0.01% 776
2024
Q2
$228K Buy
1,212
+1,210
+60,500% +$224K ﹤0.01% 782
2024
Q1
$371 Hold
2
﹤0.01% 1470
2023
Q4
$364 Hold
2
﹤0.01% 1473
2023
Q3
$353 Hold
2
﹤0.01% 1432
2023
Q2
$377 Hold
2
﹤0.01% 1321
2023
Q1
$390 Hold
2
﹤0.01% 1319
2022
Q4
$367 Hold
2
﹤0.01% 1251
2022
Q3
$0 Hold
2
﹤0.01% 1320
2022
Q2
$0 Sell
2
-30
-94% -$4.87K ﹤0.01% 1381
2022
Q1
$5K Buy
+32
New +$5.45K ﹤0.01% 1080

Other funds holding MSGS

Clearstead Advisors's MSGS Position: Q2 2026 in Review

Clearstead Advisors increased its Madison Square Garden (MSGS) stake by 1,600% in Q2 2026, buying an estimated $11.3K and bringing the position to 34 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1897.

Clearstead Advisors first reported a position in MSGS in Q1 2022 and has held it in 18 quarters since. The position peaked at $276K in Q3 2025. 468 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Clearstead Advisors held 34 shares of Madison Square Garden worth $13.7K as of Q2 2026.
  • Clearstead Advisors bought 32 Madison Square Garden shares in Q2 2026, an estimated $11.3K.
  • Madison Square Garden made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1897 holding.
  • Clearstead Advisors first reported a position in Madison Square Garden in Q1 2022 and has held it in 18 quarters since.
  • Clearstead Advisors's Madison Square Garden position peaked at $276K in Q3 2025.
  • 468 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.